Ukraine comes back to haunt share market
Teva wins approval for generic version of Lovaza.
Renewed worries about Ukraine pushed shares prices around the world and in Tel Aviv sharply lower on Tuesday. The Tel Aviv Stock Exchange’s TA-25 index finished down 1.1% at 1,406.77 points, while the TA-100 lost 1.3% to a 1,281.19 finish, on turnover of 1.82 billion shekels ($523 million). Arbitrage shares such as Teva Pharmaceuticals and Perrigo were hit hard after Wall Street...
Like us on Facebook and get articles directly in your news feed